Financial Disclosures

The White House defended President Trump’s extensive stock trading activity, totaling thousands of transactions. Vice President Vance stated the President does not personally manage his investments, relying on independent advisors and discretionary accounts managed by third-party institutions. The Trump Organization clarified that neither the President nor his family are involved in specific investment decisions, aiming to address concerns about conflicts of interest. Vance also reiterated his support for banning public officials from trading stocks.

Sinovac Biotech Ltd. received a Nasdaq notification for non-compliance with listing rules due to delayed financial filings. This adds to a previous delisting determination, with a hearing scheduled for January 8, 2026. The company is preparing to present its plan to rectify the issue and maintain its Nasdaq listing.